Lucus Advisors’s Core Laboratories CLB Stock Holding History

Lucus Advisors’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-2,824	Closed	-$350K	–	232
2016 Q2	$350K	Buy	+2,824	New	+$341K	0.29%	102

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Lucus Advisors's CLB Position: Q3 2016 in Review

Lucus Advisors sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 2,824 shares — an estimated $350K sold.

Lucus Advisors first reported a position in CLB in Q2 2016 and held it in 1 quarter. The position peaked at $350K in Q2 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

Lucus Advisors reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
Lucus Advisors sold 2,824 Core Laboratories shares in Q3 2016, an estimated $350K.
Lucus Advisors first reported a position in Core Laboratories in Q2 2016 and held it in 1 quarter.
Lucus Advisors's Core Laboratories position peaked at $350K in Q2 2016.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Lucus Advisors's 13F filing for Q3 2016, filed 4 Nov 2016.